KALA (KALA BIO, Inc. Common Stock) Stock Analysis - Analyst Ratings
KALA BIO, Inc. Common Stock (KALA) is a publicly traded Healthcare sector company. As of May 21, 2026, KALA trades at $2.67 with a market cap of $50.38M and a P/E ratio of -0.82. KALA moved +4.35% today. Year to date, KALA is -91.40%; over the trailing twelve months it is -98.66%. Its 52-week range spans $2.52 to $1,030.00. Rallies surfaces KALA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What do analysts rate KALA?
The average price target is $0.00.
KALA Key Metrics
Key financial metrics for KALA
Metric
Value
Price
$2.67
Market Cap
$50.38M
P/E Ratio
-0.82
EPS
$-3.31
Dividend Yield
0.00%
52-Week High
$1,030.00
52-Week Low
$2.52
Volume
9
Avg Volume
0
Revenue (TTM)
$0
Net Income
$-26.98M
Gross Margin
0.00%
KALA Analyst Consensus
KALA analyst coverage data. Average price target: $0.00.
